A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma.
about
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory NeuroblastomaEarly investigational tubulin inhibitors as novel cancer therapeutics.Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy.The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells.A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma.
P2860
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A Phase 1 Trial of TPI 287 as ...... roblastoma or Medulloblastoma.
@en
A Phase 1 Trial of TPI 287 as ...... roblastoma or Medulloblastoma.
@nl
type
label
A Phase 1 Trial of TPI 287 as ...... roblastoma or Medulloblastoma.
@en
A Phase 1 Trial of TPI 287 as ...... roblastoma or Medulloblastoma.
@nl
prefLabel
A Phase 1 Trial of TPI 287 as ...... roblastoma or Medulloblastoma.
@en
A Phase 1 Trial of TPI 287 as ...... roblastoma or Medulloblastoma.
@nl
P2093
P2860
P356
P1476
A Phase 1 Trial of TPI 287 as ...... roblastoma or Medulloblastoma.
@en
P2093
Alyssa Vander Werff
Deanna Mitchell
Genevieve Bergendahl
Gina K Hanna
Giselle L Saulnier Sholler
Jacqueline Kraveka
Joel Kaplan
Mike DeSarno
Takamaru Ashikaga
P2860
P356
10.1002/PBC.25687
P577
2015-07-31T00:00:00Z